Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimization of Minocycline-containing Bismuth Quadruple Therapy for Helicobacter Pylori Rescue Treatment
NCT06561711Phase 4Completed
- Sponsor
- Shanghai Jiao Tong University School of Medicine
- Start
- Aug 2024
- Primary completion
- Feb 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of minocycline in Helicobacter pylori infection (4 arms), sponsored by Shanghai Jiao Tong University School of Medicine. Primary endpoint: Helicobacter pylori eradication rate at 6 weeks. Started Aug 2024; status: completed.
02
Drugs
minocycline
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT06561711.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06561711.